$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Find out what happened in a roller coaster year — and join our competition to choose five shares for 2021
After a turbulent decade, the Indian pharma group has role in delivering Covid-19 jab
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them even for viral infections, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Recommendations from an FT roundtable with pharma, government, and NGO experts
A South African doctor’s prescription to stop poorer countries losing access to many of modern medicine’s advances
Group will travel to mainland China as wider inoculation rollout delayed in territory
US president signals incoming administration will be unable to dramatically speed up vaccinations
Senior scientific adviser says it would be unwise to reopen England’s pubs and restaurants until May
Government’s strategy of delaying second doses may still backfire
Lockdown extended amid estimates B.1.1.7 variant will account for most new infections by March
London and Midlands sent 400 MoD staff and 110 being deployed to Northern Ireland to ease NHS pressure
Country is first EU state to break ranks and give unilateral emergency approval for Covid jab
Delivery around the world is a new line of potential business
Government sets 2m a day target as it tries to shake off dependence on foreign manufacturing
As developed countries race to roll out Covid-19 jabs, poorer nations fear they are missing out
Household names like McDonald’s start to modify practices to aid farm animals’ health, growth and digestion
More than 4,400 fatalities reported on Wednesday as president warns of tough times to come
Government accused of complacency as health experts warn of fast-spreading strains
Imperial College study shows ‘no evidence of decline’ and slowly increasing R number
PM suggests Britain can give speedy approval to any jabs needed to deal with new variants of virus
Even with rising infections, providers say better controls and vaccine rollout are preventing mass outbreak
Group serving over-50s will only allow people to travel after receiving two doses of jab
European officials say supply changes after ruling on doses per vial could derail vaccination plans
Demand for Sinovac’s CoronaVac will remain high. In most developing countries, it is the only option
International Edition
